The authors reply
We would like to thank Tan et al.1 for validating and confirming our antineutrophil cytoplasm antibody (ANCA) renal risk score.2 In a retrospective, single-center London cohort of 178 patients, the score determined renal survival dependent on patients’ risk groups at the 36-month follow-up (P
Source: Kidney International - Category: Urology & Nephrology Authors: Silke R. Brix, Rolf A.K. Stahl, Thorsten Wiech Tags: Letter to the Editor Source Type: research
More News: Urology & Nephrology